Citigroup’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,100
Closed -$2.04M 5713
2025
Q1
$2.04M Sell
20,100
-3,400
-14% -$332K ﹤0.01% 2697
2024
Q4
$2.17M Buy
+23,500
New +$2.31M ﹤0.01% 2747

Other funds holding EHC

Citigroup's EHC Position: Q2 2026 in Review

Citigroup reduced its Encompass Health (EHC) stake by 14% in Q2 2026, selling an estimated $637K and leaving 37,374 shares worth $3.78M. The position accounts for ﹤0.01% of the portfolio, ranked #2388.

Citigroup first reported a position in EHC in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.58M in Q4 2018. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Citigroup held 37,374 shares of Encompass Health worth $3.78M as of Q2 2026.
  • Citigroup sold 6,149 Encompass Health shares in Q2 2026, an estimated $637K.
  • Encompass Health made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2388 holding.
  • Citigroup first reported a position in Encompass Health in Q2 2013 and has held it in 53 quarters since.
  • Citigroup's Encompass Health position peaked at $7.58M in Q4 2018.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.